FindTrial
Sign In

Treatment Preferences for Patients with Esophageal Cancer in Japan

Treatment Preferences for Patients with Esophageal Cancer in Japan - PPEC Study

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000051224
Enrollment
150
Registered
2023-06-12
Start date
2023-08-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Sponsors

Ono Pharmaceutical Co., Ltd. Bristol-Myers Squibb K.K.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Signed informed consent 2. Age18 years or more 3.Self reported esophageal cancer

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
DCE-based relative importance of attributes in patients with esophageal cancer—

Secondary

MeasureTime frame
Trade-offs between DCE-based attributes and subgroup analyses based on patient and clinical characteristics in patients with esophageal cancer—

Countries

Japan

Contacts

Public ContactTshioaki Murofushi

INTAGE Healthcare, Inc Market Access, Marketing Insight

toshiaki.murofushi@intage.com03-5294-8393

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026